Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells

Overview of attention for article published in Frontiers in immunology, April 2024

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 8 Mendeley

So far, Altmetric has seen 1 X post from an account with 49 followers.

Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells https://t.co/8OcxAaIH5y #FrontImmunol

04 Apr 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.